Skip to main content
STVN logo
STVN
(NYSE)
Stevanato Group S.p.A.
$17.75-- (--)
Loading... - Market loading

Stevanato Group S.p.A. (STVN) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Stevanato Group S.p.A.
STVNNew York Stock Exchange

About Stevanato Group S.p.A.

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Company Information

CEOFranco Stevanato
Founded1949
Employees6,010
CountryItaly
Fiscal YearJanuary - December

Stock Details

ExchangeNew York Stock Exchange (NYSE)
CurrencyUSD - USD
TypeStock

Contact Information

Phone39 04 99 31 811
Address
Via Molinella 17 Piombino Dese, PD 35017 Italy

Corporate Identifiers

CUSIPT9224W109
ISINIT0005452658
SIC8731

Leadership Team & Key Executives

Franco Stevanato
Chief Executive Officer
Marco Dal Lago
Chief Financial Officer
Lisa Miles
Head of Investor Relations